Genetic analysis of patients with leukemic transformation of myeloproliferative neoplasms shows recurrent
SRSF2
mutations that are associated with adverse outcome
Supplemental materials for Zhang et al
Files in this Data Supplement:
Document 1. Supplemental Tables and Figures (PDF, 3.3 MB)